Featured Firms
Presented by BigVoodoo
Genome Therapeutics Corp. gained its first commercial drug product with the acquisition of GeneSoft Pharmaceuticals Inc. Lawyers at Gunderson Dettmer represented South San Francisco-based GeneSoft in the all-stock transaction valued at $80 million. The deal was finalized seven months after the FDA approved GeneSoft's Factive for treatment of acute bacterial exacerbations of chronic bronchitis and pneumonia.
December 04, 2003 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS